Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ryboquin

Ryboquin
2013 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$2.34M LATEST DEAL AMOUNT
6 INVESTORS
Description

Developer of nano-technology and gene therapy designed to treat cancer. The company's nano-technology and gene therapy commercializes human cancer medicines and tumor apoptosis enhancer drug to optimize chemotherapy, enabling patients to access effective oncology therapies.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Ettrick Riverside, Dunsdale Road
  • Scottish Borders
  • Selkirk TD7 5EB
  • Scotland, United Kingdom

+44 0844 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ryboquin’s full profile, request a free trial.

Ryboquin Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 27-Jul-2017 $2.34M 00.000 00.000 Completed Startup
1. Early Stage VC 07-Jan-2016 00.000 00.000 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Ryboquin Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Ordinary 1 00,000,000 00.000000 00.00 00.00 00 00.00 00.00
Ordinary 000,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Ryboquin Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 19-Jul-2018 000000000000000000 00.000 Other Healthcare Technology Systems 0000 000000
To view this company’s complete investment and acquisition history, request access »

Ryboquin Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Brian Kennedy Angel (individual) Minority 000 0000 000000 0
Brian Souter Angel (individual) Minority 000 0000 000000 0
Braveheart Investment Group Venture Capital Minority 000 0000 000000 0
Scottish Enterprise Venture Capital Minority 000 0000 000000 0
Strathtay Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Ryboquin Executive Team (3)

Name Title Board
Seat
Contact
Info
Alan Walker Ph.D Chief Executive Officer & Board Member
David Harrison Ph.D Non-Executive Director
Simon Newman Ph.D Chief Scientific Officer

Ryboquin Board Members (6)

Name Representing Role Since Contact
Info
Alan Walker Ph.D Ryboquin Chief Executive Officer & Board Member 000 0000
Alistair Strachan Ph.D Self Board Member 000 0000
Brian Kennedy Ryboquin Board Member 000 0000
Matthew Benson Self Non-Executive Director 000 0000
Paul Murray Ryboquin Non-Executive Chairman 000 0000
You’re viewing 5 of 6 board members. Get the full list »